共 50 条
- [23] PIRADS ≥ 4 MRI lesion: Is performing systematic biopsies still essential for detecting clinically significant prostate cancer? FRENCH JOURNAL OF UROLOGY, 2024, 34 (02):
- [24] USEFULNESS OF FREE PSA RATIO TO ENHANCE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN PATIENTS WITH PIRADS <3 AND PSA ≤10 JOURNAL OF UROLOGY, 2024, 211 (05): : E785 - E786
- [26] PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer Prostate Cancer and Prostatic Diseases, 2023, 26 : 347 - 352
- [27] Re: Risk of Clinically Significant Prostate Cancer Associated with Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI Editorial Comment JOURNAL OF UROLOGY, 2018, 200 (01): : 11 - 11
- [28] WHERE IS MP-MRI MORE ACCURATE IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER? AN ANALYSIS BASED ON ANATOMICAL PROSTATE AREAS JOURNAL OF UROLOGY, 2019, 201 (04): : E518 - E518
- [29] PREDICTIVE VALUE OF PIRADS V2 FOR ANY AND CLINICALLY SIGNIFICANT PROSTATE CANCER ON PROSTATE BIOPSY IN A HIGH RISK ETHNIC COHORT JOURNAL OF UROLOGY, 2018, 199 (04): : E183 - E184